Civic IQ
PROFESSIONAL_SERVICESONGOING

Texas Department of Health and Human Services Anticonvulsant Drug Interactions Report February 2026

Texas HHS uses Acentra Health for DUR intervention

Texas Health and Human ServicesACENTRA HEALTHFebruary 1, 2026

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

The Texas Department of Health and Human Services utilized Acentra Health to conduct a retrospective drug utilization review on anticonvulsant interactions for Medicaid members, including analytics via the RxExplorer application and prescriber intervention mailings. The engagement supported population-based DUR letters and post-intervention outcome and cost-savings analysis over defined pre- and post-periods.

Contract Details

Vendor

ACENTRA HEALTH

Agency

Texas Health and Human Services, TX

Contract Type

PROFESSIONAL_SERVICES

Document Date

February 1, 2026

Contract Term

Intervention process executed June 23, 2025 – January 12, 2026 (pre- and post-intervention evaluation periods defined in report)

Renewal Info

Underlying contract appears to cover DUR analytics and intervention mailings; specific renewal terms are not described in the report.

More from ACENTRA HEALTH

Related Contracts

Bring us your territory.
We'll show you what is forming.

See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.

Try Civic IQ for free